These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31237158)

  • 1. Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART.
    Völz S; Angerås O; Koul S; Haraldsson I; Sarno G; Venetsanos D; Grimfärd P; Ulvenstam A; Hofmann R; Hamid M; Henareh L; Wagner H; Jensen J; Danielewicz M; Östlund O; Eriksson P; Scherstén F; Linder R; Råmunddal T; Pétursson P; Fröbert O; James S; Erlinge D; Omerovic E
    Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):510-519. PubMed ID: 31237158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial.
    Venetsanos D; Sederholm Lawesson S; Fröbert O; Omerovic E; Henareh L; Robertsson L; Linder R; Götberg M; James S; Alfredsson J; Erlinge D; Swahn E
    Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):502-509. PubMed ID: 30351167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction.
    Erlinge D; Koul S; Omerovic E; Fröbert O; Linder R; Danielewicz M; Hamid M; Venetsanos D; Henareh L; Pettersson B; Wagner H; Grimfjärd P; Jensen J; Hofmann R; Ulvenstam A; Völz S; Petursson P; Östlund O; Sarno G; Wallentin L; Scherstén F; Eriksson P; James S
    Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):492-501. PubMed ID: 30281320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.
    Wester A; Attar R; Mohammad MA; Isma N; James S; Omerovic E; Erlinge D; Koul S
    Circ Cardiovasc Interv; 2020 Apr; 13(4):e008671. PubMed ID: 32216471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
    Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
    Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
    Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
    James S; Koul S; Andersson J; Angerås O; Bhiladvala P; Calais F; Danielewicz M; Fröbert O; Grimfjärd P; Götberg M; Henareh L; Ioanes D; Jensen J; Linder R; Lindroos P; Omerovic E; Panayi G; Råmunddal T; Sarno G; Ulvenstam A; Völtz S; Wagner H; Wikström H; Östlund O; Erlinge D
    Circ Cardiovasc Interv; 2021 Dec; 14(12):e008969. PubMed ID: 34903034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
    Bikdeli B; Erlinge D; Valgimigli M; Kastrati A; Han Y; Steg PG; Stables RH; Mehran R; James SK; Frigoli E; Goldstein P; Li Y; Shahzad A; Schüpke S; Mehdipoor G; Chen S; Redfors B; Crowley A; Zhou Z; Stone GW
    Circulation; 2023 Oct; 148(16):1207-1219. PubMed ID: 37746717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial.
    Hamon M; Coste P; Van't Hof A; Ten Berg J; Clemmensen P; Tabone X; Benamer H; Kristensen SD; Cavallini C; Marzocchi A; Hamm C; Kanic V; Bernstein D; Anthopoulos P; Deliargyris EN; Steg PG
    Circ Cardiovasc Interv; 2015 Jun; 8(6):e002049. PubMed ID: 26056249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Use of Bivalirudin and Radial Access in Acute Coronary Syndromes Is Not Superior to the Use of Either One Separately: Meta-Analysis of Randomized Controlled Trials.
    Mina GS; Gobrial GF; Modi K; Dominic P
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1523-31. PubMed ID: 27491601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice.
    Zhang Y; Zhang Y; Liu Z; Zhang B; Liu G; Chen K
    Biomed Pharmacother; 2020 Oct; 130():110758. PubMed ID: 34321166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
    Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Shah RM; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2376-2386. PubMed ID: 27838271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years.
    Omerovic E; James S; Råmundal T; Fröbert O; Linder R; Danielewicz M; Hamid M; Pagonis C; Henareh L; Wagner H; Stewart J; Jensen J; Lindros P; Robertsson L; Wikström H; Ulvenstam A; Bhiladval P; Tödt T; Ioanes D; Kellerth T; Zagozdzon L; Götberg M; Andersson J; Angerås O; Östlund O; Held C; Koul S; Erlinge D
    Cardiovasc Revasc Med; 2024 Sep; 66():43-50. PubMed ID: 38575449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: experience from a single center.
    Singh A; Edasery D; Noor A; Bhasin N; Kaplan B; Jauhar R
    J Invasive Cardiol; 2011 Mar; 23(3):101-4. PubMed ID: 21364238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Huang X; Chen S; Redfors B; Zhang Y; Souza CF; Mehran R; Bansilal S; Kirtane AJ; Brener SJ; Feite F; Dangas GD; Ben-Yehuda O; Stone GW
    Coron Artery Dis; 2020 Jan; 31(1):59-65. PubMed ID: 31809479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary Intervention.
    Matthews AA; Szummer K; Dahabreh IJ; Lindahl B; Erlinge D; Feychting M; Jernberg T; Berglund A; Hernán MA
    J Am Heart Assoc; 2021 Jun; 10(11):e020357. PubMed ID: 33998290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
    Erlinge D; Omerovic E; Fröbert O; Linder R; Danielewicz M; Hamid M; Swahn E; Henareh L; Wagner H; Hårdhammar P; Sjögren I; Stewart J; Grimfjärd P; Jensen J; Aasa M; Robertsson L; Lindroos P; Haupt J; Wikström H; Ulvenstam A; Bhiladvala P; Lindvall B; Lundin A; Tödt T; Ioanes D; Råmunddal T; Kellerth T; Zagozdzon L; Götberg M; Andersson J; Angerås O; Östlund O; Lagerqvist B; Held C; Wallentin L; Scherstén F; Eriksson P; Koul S; James S
    N Engl J Med; 2017 Sep; 377(12):1132-1142. PubMed ID: 28844201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.